Compare Abbott Laboratories (ABT) vs Sezzle Inc (SEZL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Sezzle Inc — how do they compare? Abbott Laboratories trades at $95.45 (market cap $166.94B), while Sezzle Inc trades at $169.52 (market cap $5.97B). The key difference: Abbott Laboratories is far larger — about 28× Sezzle Inc's market cap, and Abbott Laboratories pays a 2.63% dividend while Sezzle Inc pays none. Which is the better fit depends on your goals.
| ABT | SEZL | |
|---|---|---|
Market Cap | $166.94B | $5.97B |
Sector | Health | Technology |
52-Week High | $136.62 | $183.24 |
52-Week Low | $82.57 | $50.97 |
Enterprise Value | $193.69B | $6.00B |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Sezzle (SEZL) trades at $179.05, down 2.29% today, but maintains a strong bullish technical trend with moving averages supporting further upside. Fundamentally, the company exhibits robust profitability with a 30.83% net income margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights product expansion and strong Q1 2026 results, driving positive sentiment.
The outlook remains positive given accelerating revenue growth and raised guidance, though risks include potential securities litigation and high valuation multiples. Analysts are predominantly bullish with a consensus price target of $146.40, suggesting caution near-term, but operational momentum supports long-term growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Sezzle Inc
Sezzle Inc is a financial technology company that operates a Buy Now, Pay Later (BNPL) payment platform. The company allows consumers to make purchases and split the total cost into four interest-free payments over six weeks, primarily serving the e-commerce retail market. Sezzle focuses on promoting financial empowerment by offering a transparent and responsible payment solution to customers at the point of sale.
Read more on SEZL →
